Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests
A new drug being developed by Pfizer offers the possibility of nearly putting an end to deaths from COVID-19. When given within five days of the onset of symptoms, the antiviral therapy called Paxlovid, prevented almost 90% of deaths from COVID-19 compared to a placebo, a Pfizer study found. By the end of the year,…